Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 9, 2014, Pages 1865-1874

  Girardi, Cristina ^a,b   James, Peter ^c   Zanin, Sofia ^a,b   Pinna, Lorenzo A ^a,b,c   Ruzzene, Maria ^a,b,d  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

^c LUND UNIVERSITY   (Sweden)

^d VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

Akt; Casein kinase 2; CK2; CKII; Isoform specificity; PKB

Indexed keywords

CASEIN KINASE II; ISOENZYME; PROTEIN KINASE B; PROTEIN KINASE B ALPHA; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; STEREOSPECIFICITY; WESTERN BLOTTING;

AKT; CASEIN KINASE 2; CK2; CKII; ISOFORM SPECIFICITY; PKB;

AMINO ACID SEQUENCE; ANIMALS; CASEIN KINASE II; CELL LINE; CYTOSKELETAL PROTEINS; DISULFIDES; ISOENZYMES; MASS SPECTROMETRY; MICE; MOLECULAR SEQUENCE DATA; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN DENATURATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS;

EID: 84902491248     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.04.020     Document Type: Article

References (64)

1. Fayard E., Tintignac L.A., Baudry A., Hemmings B.A. Protein kinase B/Akt at a glance. J. Cell Sci. 2005, 118:5675-5678.
2. Woodgett J.R. Recent advances in the protein kinase B signaling pathway. Curr. Opin. Cell Biol. 2005, 17:150-157.
3. Toker A., Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res. 2006, 66:3963-3966.
4. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
5. Sale E.M., Sale G.J. Protein kinase B: signalling roles and therapeutic targeting. Cell. Mol. Life Sci. 2008, 65:113-127.
6. Yang Z.Z., Tschopp O., Hemmings-Mieszczak M., Feng J., Brodbeck D., Perentes E., Hemmings B.A. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J. Biol. Chem. 2003, 278:32124-32131.
7. Santi S.A., Lee H. The Akt isoforms are present at distinct subcellular locations. Am. J. Physiol. Cell Physiol. 2010, 298:C580-C591.
8. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
9. Bozulic L., Surucu B., Hynx D., Hemmings B.A. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol. Cell 2008, 30:203-213.
10. Bae S.S., Cho H., Mu J., Birnbaum M.J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 2003, 278:49530-49536.
11. Cho H., Thorvaldsen J.L., Chu Q., Feng F., Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 2001, 276:38349-38352.
12. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
13. Bellacosa A., Testa J.R., Moore R., Larue L. A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities. Cancer Biol. Ther. 2004, 3:268-275.
14. Stambolic V., Woodgett J.R. Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration. Trends Cell Biol. 2006, 16:461-466.
15. Yoeli-Lerner M., Yiu G.K., Rabinovitz I., Erhardt P., Jauliac S., Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 2005, 20:539-550.
16. Irie H.Y., Pearline R.V., Grueneberg D., Hsia M., Ravichandran P., Kothari N., Natesan S., Brugge J.S. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 2005, 171:1023-1034.
17. Liu H., Radisky D.C., Nelson C.M., Zhang H., Fata J.E., Roth R.A., Bissell M.J. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:4134-4139.
18. Yoeli-Lerner M., Toker A. Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle 2006, 5:603-605.
19. Chin Y.R., Toker A. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell. Signal. 2009, 21:470-476.
20. Toker A. Achieving specificity in Akt signaling in cancer. Adv. Biol. Regul. 2012, 52:78-87.
21. Chin Y.R., Toker A. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol. Cell 2010, 38:333-344.
22. Unger G.M., Davis A.T., Slaton J.W., Ahmed K. Protein kinase CK2 as regulator of cell survival: implications for cancer therapy. Curr. Cancer Drug Targets 2004, 4:77-84.
23. Ahmad K.A., Wang G., Slaton J., Unger G., Ahmed K. Targeting CK2 for cancer therapy. Anticancer Drugs 2005, 16:1037-1043.
24. Pagano M.A., Cesaro L., Meggio F., Pinna L.A. Protein kinase CK2: a newcomer in the 'druggable kinome'. Biochem. Soc. Trans. 2006, 34:1303-1306.
25. Sarno S., Pinna L.A. Protein kinase CK2 as a druggable target. Mol. Biosyst. 2008, 4:889-894.
26. Duncan J.S., Litchfield D.W. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim. Biophys. Acta 2008, 1784:33-47.
27. Siddiqui-Jain A., Drygin D., Streiner N., Chua P., Pierre F., O'Brien S.E., Bliesath J., Omori M., Huser N., Ho C., Proffitt C., Schwaebe M.K., Ryckman D.M., Rice W.G., Anderes K. CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer Res. 2010, 70:10288-10298.
28. Ruzzene M., Pinna L.A. Addiction to protein kinase CK2: a common denominator of diverse cancer cells?. Biochim. Biophys. Acta 2010, 1804:499-504.
29. Arevalo M.A., Rodriguez-Tebar A. Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3beta and stimulate axonal growth. Mol. Biol. Cell 2006, 17:3369-3377.
30. Guerra B. Protein kinase CK2 subunits are positive regulators of AKT kinase. Int. J. Oncol. 2006, 28:685-693.
31. Di Maira G., Salvi M., Arrigoni G., Marin O., Sarno S., Brustolon F., Pinna L.A., Ruzzene M. Protein kinase CK2 phosphorylates and upregulates Akt/PKB. Cell Death Differ. 2005, 12:668-677.
32. Di Maira G., Brustolon F., Pinna L.A., Ruzzene M. Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells. Cell. Mol. Life Sci. 2009, 66:3363-3373.
33. Sarno S., Ghisellini P., Cesaro L., Battistutta R., Pinna L.A. Generation of mutants of CK2alpha which are dependent on the beta-subunit for catalytic activity. Mol. Cell. Biochem. 2001, 227:13-19.
34. Romano S., Milan G., Veronese C., Collin G.B., Marshall J.D., Centobene C., Favaretto F., Dal Pra C., Scarda A., Leandri S., Naggert J.K., Maffei P., Vettor R. Regulation of Alström syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity. Int. J. Mol. Med. 2008, 21:731-736.
35. Ruzzene M., Di Maira G., Tosoni K., Pinna L.A. Assessment of CK2 constitutive activity in cancer cells. Methods Enzymol. 2010, 484:495-514.
36. Thingholm T.E., Jensen O.N., Robinson P.J., Larsen M.R. SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol. Cell. Proteomics 2008, 7:661-671.
37. Pinna L.A., Ruzzene M. How do protein kinases recognize their substrates?. Biochim. Biophys. Acta 1996, 1314:191-225.
38. Gherzi R., Trabucchi M., Ponassi M., Gallouzi I.E., Rosenfeld M.G., Briata P. Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ. 2010, 17:975-983.
39. Turowec J.P., Vilk G., Gabriel M., Litchfield D.W. Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2alpha': implications for pathological roles of CK2 in promoting cancer cell survival. Oncotarget 2013, 4:560-571.
40. Woods Y.L., Cohen P., Becker W., Jakes R., Goedert M., Wang X., Proud C.G. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem. J. 2001, 355:609-615.
41. Wani R., Qian J., Yin L., Bechtold E., King S.B., Poole L.B., Paek E., Tsang A.W., Furdui C.M. Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:10550-10555.
42. Wani R., Bharathi N.S., Field J., Tsang A.W., Furdui C.M. Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle. Cell Cycle 2011, 10:3263-3268.
43. Heron-Milhavet L., Khouya N., Fernandez A., Lamb N.J. Akt1 and Akt2: differentiating the aktion. Histol. Histopathol. 2011, 26:651-662.
44. Kane S., Sano H., Liu S.C., Asara J.M., Lane W.S., Garner C.C., Lienhard G.E. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J. Biol. Chem. 2002, 277:22115-22118.
45. Kovacina K.S., Park G.Y., Bae S.S., Guzzetta A.W., Schaefer E., Birnbaum M.J., Roth R.A. Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J. Biol. Chem. 2003, 278:10189-10194.
46. Ponce D.P., Yefi R., Cabello P., Maturana J.L., Niechi I., Silva E., Galindo M., Antonelli M., Marcelain K., Armisen R., Tapia J.C. CK2 functionally interacts with AKT/PKB to promote the beta-catenin-dependent expression of survivin and enhance cell survival. Mol. Cell. Biochem. 2011, 356:127-132.
47. Vandromme M., Rochat A., Meier R., Carnac G., Besser D., Hemmings B.A., Fernandez A., Lamb N.J. Protein kinase B beta/Akt2 plays a specific role in muscle differentiation. J. Biol. Chem. 2001, 276:8173-8179.
48. Heron-Milhavet L., Franckhauser C., Rana V., Berthenet C., Fisher D., Hemmings B.A., Fernandez A., Lamb N.J. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol. Cell. Biol. 2006, 26:8267-8280.
49. Gao D., Inuzuka H., Tseng A., Chin R.Y., Toker A., Wei W. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat. Cell Biol. 2009, 11:397-408.
50. Brognard J., Sierecki E., Gao T., Newton A.C. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell 2007, 25:917-931.
51. Cenni V., Bavelloni A., Beretti F., Tagliavini F., Manzoli L., Lattanzi G., Maraldi N.M., Cocco L., Marmiroli S. Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2). Mol. Biol. Cell 2011, 22:2946-2956.
52. Cariaga-Martinez A.E., Lopez-Ruiz P., Nombela-Blanco M.P., Motino O., Gonzalez-Corpas A., Rodriguez-Ubreva J., Lobo M.V., Cortes M.A., Colas B. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells. Cell. Signal. 2013, 25:1586-1597.
53. Calleja V., Laguerre M., Parker P.J., Larijani B. Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol. 2009, 7:e17.
54. Wu W.I., Voegtli W.C., Sturgis H.L., Dizon F.P., Vigers G.P., Brandhuber B.J. Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition. PLoS One 2010, 5:e12913.
55. Chin Y.R., Toker A. Akt2 regulates expression of the actin-bundling protein palladin. FEBS Lett. 2010, 584:4769-4774.
56. Zhou G.L., Tucker D.F., Bae S.S., Bhatheja K., Birnbaum M.J., Field J. Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration. J. Biol. Chem. 2006, 281:36443-36453.
57. Kim E.K., Tucker D.F., Yun S.J., Do K.H., Kim M.S., Kim J.H., Kim C.D., Birnbaum M.J., Bae S.S. Linker region of Akt1/protein kinase Balpha mediates platelet-derived growth factor-induced translocation and cell migration. Cell. Signal. 2008, 20:2030-2037.
58. Cristiano B.E., Chan J.C., Hannan K.M., Lundie N.A., Marmy-Conus N.J., Campbell I.G., Phillips W.A., Robbie M., Hannan R.D., Pearson R.B. A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition. Cancer Res. 2006, 66:11718-11725.
59. Hart J.R., Vogt P.K. Phosphorylation of AKT: a mutational analysis. Oncotarget 2011, 2:467-476.
60. Maira S.M., Galetic I., Brazil D.P., Kaech S., Ingley E., Thelen M., Hemmings B.A. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science 2001, 294:374-380.
61. Tokuda E., Fujita N., Oh-hara T., Sato S., Kurata A., Katayama R., Itoh T., Takenawa T., Miyazono K., Tsuruo T. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res. 2007, 67:9666-9676.
62. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15:6541-6551.
63. Conus N.M., Hannan K.M., Cristiano B.E., Hemmings B.A., Pearson R.B. Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase. J. Biol. Chem. 2002, 277:38021-38028.
64. Meier R., Alessi D.R., Cron P., Andjelkovic M., Hemmings B.A. Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta. J. Biol. Chem. 1997, 272:30491-30497.